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Abstract
An analytical review of pharmacopoeial aspects of preparation of infusions and decoctions in pharmacies is presented.
The aim of this work is to conduct a comparative analysis of pharmacopoeial requirements for the technology of infusions 
and decoctions in pharmacies.
Materials and methods of the research. Comparative analysis of pharmacopoeial requirements was performed using me-
thods of systematic and structural-logical analysis.
Results and discussions. It was found that in many pharmacopoeias (European, British, Italian, French, Czech, Kazakh) 
there are no instructions on the pharmacy technology of these dosage forms. Only the pharmacopoeias of Japan, Austria, Belarus 
and Russia contain separate monographs on the extemporaneous preparation of infusions and decoctions.
After analyzing these monographs, it was found that the definition of infusions and decoctions as a dosage form differs. It was 
found that the Japanese Pharmacopoeia regulates the preliminary preparation of medicinal plant raw materials (soaking for 5 minutes in 
water), in other pharmacopoeias there is no such requirement. When conducting a comparative analysis of the techno logy of preparation of 
infusions and decoctions, we observe that the ratio of medicinal plant raw materials (MPRM) and extractant and extraction modes differ. 
Conclusions. An analytical review of pharmacopoeial aspects of preparation of infusions and decoctions in pharmacies is 
presented.
A comparative analysis of the requirements for technology and quality control of infusions and decoctions in accordance 
with pharmacopoeial articles revealed both different and similar information. The results of the research showed that despite the 
differences in the structures of articles and names, as well as approaches to the definition of this dosage form, some requirements 
are similar (particle size of MPRM). The differences that were found include the ratio of MPRM and extractant, extraction modes.
Taking into account the data of the analysis and the existing national requirements, the authors proposed a draft general 
pharmacopoeial article «Infusions and decoctions made in pharmacies».
Keywords: pharmacopoeias, monographs, pharmacopoeial articles, infusions, decoctions, medicinal plant raw materials, 
analysis, requirements, extemporaneous technology, quality indicators.
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1. Introduction
In medical practice, an important place is occupied by herbal medicines, the share of which 
in the pharmaceutical market of developed countries reaches more than 50 %. Medicinal plant raw 
materials (MPRM) are widely used in medical practice. Of course, herbal medicines cannot com-
pletely replace therapy with drugs of synthetic origin, but can find effective use in the treatment 
of various diseases. In the preparation of medicines from plant raw materials, both individual sub-
stances isolated from plants and the whole complex of compounds contained in the raw materials – 
total substances – are used. However, for the full use of herbal medicines in medical practice, it is 
necessary to clearly understand the fact that the standardization of MPRM and technology for the 
manufacture of phytopreparations is an important condition for their effective use [1].
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Pharmaceutical development together with the fundamental elements of the quality assu-
rance system (system of good practices) constitute the general system of quality assurance of me-
dicines (Fig. 1).
Fig. 1. Components of quality assurance of pharmaceutical development of phytopreparations
In this regard, an important document for the rationing of manufacturing technology and 
quality indicators is the state pharmacopoeia or other regulations [2].
One of the simplest dosage forms of phytopreparations are infusions and decoctions.
It is worth noting that infusions and decoctions are one of the oldest dosage forms, which 
does not lose its significance due to its mild effect on the body, high bioavailability and relatively 
simple technology. These are liquid dosage forms, which are aqueous extracts from medicinal plant 
raw materials, as well as aqueous solutions of dry or liquid extracts (concentrates). They are widely 
used in medical practice both by themselves and as part of complex drugs in the form of potions, 
rinses, lotions, washes, baths, inhalations [2]. The purpose of obtaining extracts is the manufacture 
of convenient to use liquid dosage forms, and the most complete separation of biologically active 
substances from raw materials. The main factors influencing the rate and completeness of the re-
lease of active substances include [1]:
– the degree of grinding of raw materials;
– the ratio between the amount of raw materials and the volume of the finished extract;
– standard raw materials;
– histological structure of raw materials;
– temperature and infusion time;
– influence of enzymes and microflora;
– chemical composition of active substances;
– pH of the medium.
The aim of this work is to conduct a comparative analysis of pharmacopoeial requirements 
for the technology of infusions and decoctions in pharmacies. 
2. Materials and methods
Comparative analysis of pharmacopoeial requirements was performed using methods of sys-
tematic and structural-logical analysis. World pharmacopoeias were used as objects of the research.
3. Research results
The leading role in the regulation of the pharmaceutical industry has a pharmacopoeia. 
Initially, pharmacopoeias, indeed, were collections of different drugs describing the method of 
their preparation. Modern pharmacopoeia is a collection of drug standards and gives only the basic 
principles of manufacturing dosage forms.
 
The main purpose of pharmaceutical 
development of drugs based on medicinal raw 
materials 
purposeful formation of drug quality 
identification of the most important aspects that need to be controlled 
during production 
guaranteeing the probability that each unit of each batch of the 
preparation to be manufactured will have a quality that will 
correspond to its intended use 
defining the limits within which it is possible to change the process 
after implementation to ensure the established pharmacological 
action 
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The State Pharmacopoeia has a legislative nature that is mandatory for all pharmaceuticals, 
including veterinary institutions and enterprises of the country that manufacture, store, control 
and use drugs. The State Pharmacopoeia of Ukraine does not have a monograph «Infusions and 
decoctions made in pharmacies» [3–5]. Preparation of infusions and decoctions in pharmacies is 
regulated by regulations:
– by the order of the Ministry of Health of Ukraine No. 197 of September 7, 1993;
– guidelines «Requirements for the manufacture of non-sterile drugs in pharmacies» (ap-
proved by the order of the Ministry of Health of Ukraine from July 1, 2015 No. 398) [2].
Thus, it is advisable to develop a draft general pharmacopoeial article «Infusions and de-
coctions made in pharmacies». To solve this problem, it was necessary, first of all, to conduct 
a thorough analysis of the pharmacopoeial requirements of the world’s major pharmacopoeias to 
the extemporaneous technology of infusions and decoctions.
To this end, we analyzed the European, British, Italian, French, Czech, Austrian, Japanese, 
Belarusian, Kazakh and Russian pharmacopoeias.
Analyzing this information revealed that in the pharmacopoeias where this article is pre-
sent, the definition of this dosage form differs. Their analysis is presented in Table 1.
Table 1
Comparative analysis of definitions of the dosage form «Infusions and decoctions» according to the 
monographs of world pharmacopoeias
Name of the pharmacopoeia Definition
SPhU XI «Infusions and de-
coctions», RP XIII «Infusions 
and decoctions»
«Infusions and decoctions – liquid dosage forms, which are aqueous extracts from MPRM, as well 
as aqueous solutions of dry and liquid extracts (concentrates)». Medicinal substances, syrups, tinc-
tures, liquid extracts can be added to water extracts, if necessary – preservatives allowed for use
Belarusian Pharmacopoeia 
«Infusions and decoctions»
Infusions and decoctions – freshly prepared aqueous extracts from MPRM, species, herbal teas, as 
well as «…aqueous solutions of dry or liquid extracts (concentrates) for internal and external use»
Japanese Pharmacopoeia «In-
fusions and Decoctions»




Instant herbal teas consist of one or more herbal preparations (primarily extracts with or without 
the addition of essential oils) and are intended for the preparation of a solution for oral administra-
tion immediately before use. May also contain in addition to vegetable raw materials, excipients 
such as fillers (maltodextrin) and flavours
As can be seen from the data presented in Table 1, approaches to the definition of infusions 
and decoctions as dosage forms are different.
Analysis of pharmacopoeias showed that the article «Infusions and Decoctions» was in-
cluded in all editions of the Russian Pharmacopoeia, starting with the first one (1866). It should 
be noted that in the early editions of the Pharmacopoeia, in addition to general articles, there were 
separate articles on infusions and decoctions of various types of MPRM [6–10].
Starting with the 10th edition (1968), separate articles on specific infusions and decoctions 
from the pharmacopoeia were excluded. The general article on these dosage forms, despite the 
development of analytical and pharmaceutical chemistry, in all editions of the Pharmacopoeia, up 
to XI, was a specific indication of the manufacturing technology (conditions of extraction, filtra-
tion, etc.) [7]. Described in the first edition, they passed into the next with minor additions. In gene-
ral pharmacopoeial articles there were no quality indicators, not even organoleptic characteristics 
of aqueous extracts were given [7].
According to the Russian Pharmacopoeia, since 1936 (SP VIII) infusions and decoctions are 
prepared according to a certain technological scheme. The raw material is filled with water at room 
temperature, infused in a boiling water bath for 15 minutes (infusions) or 30 minutes (decoctions). It is 
then kept at room temperature for 45 minutes (infusions) or 10 minutes (decoctions) and filtered [6–10].
In RP XIII there is a general article 1.4.1.0018.15 «Infusions and decoctions» [6]. In it, in addition 
to the peculiarities of the technology, the indicators and quality criteria for the evaluation of this dosage 
form are regulated («Description», «pH of the aqueous extract», «Determination of dry residue»).
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The article on the preparation of infusions and decoctions in pharmacies was transferred to the 
Belarusian Pharmacopoeia from the Russian Pharmacopoeia of the XI edition in the same edition [11].
Analysis of the European Pharmacopoeia (EP) showed that the monograph on «Infusions 
and Decoctions» is absent. But in the EP, in the section «General monographs» there are three gen-
eral monographs: «Medicinal herbal remedies», «Medicinal herbal raw materials» and «Medicinal 
herbal teas» [12]. They summarize the definitions of plant raw materials, medicines based on it, 
the requirements for their production, and tests for identification, purity and quantification. These 
articles are cited in full in the British, Italian, Czech and Kazakh pharmacopoeias [13–18].
There is also no general article on «Infusions and Decoctions» in the American Pharma-
copoeia. However, in the section «General Chapters» there is an article «Vegetable drugs», which 
provides a method of sampling and a number of methods of pharmacognosy (impurities, common 
ash, etc.). The list of monographs includes articles on specific medicinal raw materials [19].
In the Japanese Pharmacopoeia, the section «General remarks» contains the article «Gene-
ral rules for crude Drugs», which includes a list of raw materials of plant and animal origin, as well 
as the article «Infusions and Decoctions» [20]. 
The article describes the general requirements for the size of MPRM and preparation of in-
fusions and decoctions. Thus, in accordance with the requirements of the Japanese Pharmacopoeia: 
leaves, flowers and whole plants – coarse particles (Coarse cutting); woody stems, bark, roots and 
rhizomes – moderately fine particles (Moderately fine cutting); seeds and fruits – small particles.
According to the requirements of the pharmacopoeia, infusions are prepared by adding 
50 ml of purified water to 50.0 MPRM, followed by infusion for 15 minutes, then add 900 ml of hot 
water and heat for 5 minutes, stirring. The resulting infusion is filtered.
Regarding the preparation of decoctions, the daily dose of MPRM is poured into 400–600 ml 
of purified water and heated for 30 minutes with stirring, then filtered. The resulting infusions and 
decoctions are packaged in tightly closed containers.
In the French Pharmacopoeia X edition there is a general article «Medicinal herbal raw ma-
terials», which differs in its wording from the EP, however, and here only briefly gives the concept 
of herbal raw materials and general requirements for quality control. Unfortunately, there is no 
information on the preparation of drugs with MPRM [21].
The Austrian Pharmacopoeia (Österreichisches arzneibuch) contains 3 general articles that 
regulate the preparation of infusions and decoctions, namely: Infusa «Aufgusse», Decocta «Abko-
chungen», Macerata «Mazerate» [22].
The articles pay special attention to the preliminary preparation of raw materials, a separate 
item determines the degree of grinding.
Leaves, flowers, grass are sifted through a sieve I (size of holes – 8000 μm). Woody plants, 
bark, roots, Iceland moss, Irish algae – sieve II (size of holes – 6000 μm). Fruits, seeds, plants 
containing alkaloids, blueberry leaves – sieve IV (hole size – 750 μm). Plants containing saponins, 
cardiac glycosides – sieve V (hole size – 300 μm).
Also in the articles of the Austrian Pharmacopoeia it is stated that before preparing the 
infusion and decoction of medicinal plant raw materials are soaked for 5 minutes in a mortar with 
a little water. If the medicinal plant raw material contains alkaloids, then during pre-treatment cit-
ric acid is added in an amount equal to the content of alkaloids. When using the bark of the quince 
tree use dilute hydrochloric acid in an amount of 0.5 ml per 1 g of the drug.
To make infusions and decoctions, the crushed MPRM is placed in a porcelain infusion 
tube and infused in a water bath: the decoction for 30 minutes and the infusion for 5 minutes. The 
decoction is not cooled, and the infusion is cooled at room temperature for 30 minutes.
The ratio of raw materials and extractant is also clearly regulated. For all medicinal plant 
raw materials it is 1:10. The article Infusa «Aufgusse», Decocta «Abkochungen» states that the 
ratio of raw materials and extractant, as well as the degree of grinding can be changed only on the 
advice of a doctor.
Mucus is prepared in a ratio of 5 mass fractions of raw materials per 100 ml of purified water.
The articles of the Austrian Pharmacopoeia also state that prepared infusions, decoctions 
and mucus must be labelled «Shake before use».
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4. Discussion
Thus, analyzing the technological process of preparation of infusions and decoctions, we 
observe that the ratio of MPRM and extractant and modes and duration of infusion differ [23–26].
The generalized data are given in Table 2.
Normative documentation used in Ukraine and regulating the extemporaneous technology 
of infusions and decoctions is currently represented only by the guideline «Requirements for the 
manufacture of non-sterile drugs in pharmacies» (approved by the order of the Ministry of Health 
of Ukraine from July 1, 2015 No. 398) [23]. The main approaches to the technology of infusions and 
decoctions in pharmacies are given in Table 3.
Annex B (mandatory) provides instructions for the manufacture of liquid drugs in pharma-
cies, which clearly regulates the technological process of preparation of infusions and decoctions [1].
Table 2
Comparative analysis of the ratio of components, modes of infusion preparation and decoctions according to 
the monographs of world pharmacopoeias
Indicator
Name of the pharmacopoeia
Japan Pharmacopoeia Austrian Pharmacopoeia Russian Pharmacopoeia
Preliminary prepa-
ration of MPRM
the degree of grinding is regu-
lated
the degree of grinding is regulated, 
before preparation MPRM soak in 
a mortar for 5 min with a small 
amount of the cleared water
the degree of grinding is regulated
MPRM:extractant 
ratio
infusion 1:1, followed by the ad-
dition of 900 ml of hot water;
decoctions daily dose of MPRM 
pour with 400-600 ml of puri-
fied water
1:10 depending on the chemical composition of MPRM
Preparation mode
infusion 15 minutes at room 
temperature in a water bath 
for 5 minutes;
broths are heated for 30 minutes 
with stirring
infusions for 5 minutes in a water 
bath, 30 minutes cooled at room 
temperature;
decoctions for 30 minutes insist on 
a water bath, do not cool
Depending on the volume.
up to 1000 ml of infusion for 15 minu-
tes in a water bath, cooled at room tem-
perature for 45 minutes; decoctions for 
30 minutes in a water bath, cooled at 
room temperature for 10 minutes
Table 3




The calculated amount of crushed MPRM is poured into a metal/porcelain infusion tube and filled with 
a certain volume of water. Decoctions infuse in a boiling water bath under a lid for 30 minutes, infusions – 
15 minutes. After that, they are filtered (decoctions – after 10 minutes, and infusions – after 45 minutes), the 
residue is squeezed and added to the extracts. Prepared infusions/decoctions are brought to the volume with 
boiled water according to the recipe. Infusions are cooled for at least 45 minutes (because the API extraction 
in most cases does not end during heating, and continues when the infusion is cooled). The need to strain the 
decoctions after 10 minutes of cooling is due to the fact that the colloidal solutions contained in MPRM and 
turn into decoctions, increase their viscosity and slow down the filtration. Infusions are prepared mainly from 
aboveground MPRM (leaves, flowers, grass), decoctions – from underground (roots, rhizomes, bark). If the 
volume of the water extract is more than 1000–3000 ml, the heating time in the water bath is increased for 
infusions up to 25 minutes, and for decoctions – up to 40 minutes. If the infusions/decoctions contain other 
substances (salts, syrups, tinctures, extracts), they are added to the filtered infusions/decoctions; salts should 
be only in dry form, because their addition in the form of concentrated solutions leads to dilution of extracts




Decoctions of the leaves of bearberry, root of Chinese rhubarb, rhizome of septfoil, oak bark and other MPRM 
containing tannins, should be filtered immediately after removal from the water bath; decoctions of hay leaves 
are filtered after complete cooling;
in the case of «cito» infusion in a water bath spend 25 minutes, and then the infusion is cooled artificially (wa-
ter or ice)
Expiration date Shelf life in a cool place – no more than 3 days
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Analysis of the technological process of preparation of infusions and decoctions in pharma-
cies allows to develop a general algorithm for substantiation of their technology (Fig. 2).
Fig. 2. Substantiation of technology of extemporaneous infusions and decoctions
Study limitations. The studies were limited to pharmacopoeias containing monographs on 
the dosage forms under study.
Prospects for further research. The presented algorithm of theoretical substantiation of 
the technology of extemporaneous infusions and decoctions will contribute to the standardization 
of the technological process and improve the quality of drugs.
5. Conclusions
An analytical review of pharmacopoeial aspects of preparation of infusions and decoctions 
in pharmacies is presented. It was found that in many pharmacopoeias (European, British, Italian, 
French, Czech, Kazakh) there are no instructions on the pharmacy technology of these dosage 
forms. Only the pharmacopoeias of Japan, Austria, Belarus and Russia contain separate mono-
graphs on the extemporaneous preparation of infusions and decoctions.
A comparative analysis of the requirements for technology and quality control of infusions 
and decoctions in accordance with pharmacopoeial articles revealed that despite the difference in 
the structures of articles and names, as well as approaches to determining this dosage form, some 
requirements are similar (MPRM particle size), but there are some differences (MPRM and ex-
tractant ratio, extraction modes). The analysis showed that the monograph «Infusions and Decoc-
tions» of the Pharmacopoeia of Belarus and Russia are identical, and completely repeat this article 
from the Russian Pharmacopoeia XI edition.
The Austrian Pharmacopoeia contains 3 general articles that regulate the preparation of 
infusions and decoctions, namely: Infusa «Aufgusse», Decocta «Abkochungen», Macerata «Ma-
zerate», which clearly regulates the particle size of MPRM, the ratio of raw materials and extrac-
tant, extraction mode. The article «Infusions and decoctions» of the Japanese Pharmacopoeia also 
provides clear information on the particle size of MPRM and the mode of extraction.
The results of the research will be taken into account by the authors in the development of 
the monograph of the SPhU «Infusions and decoctions made in the pharmacy». 
Conflict of interest
The authors declare that they have no conflicts of interest.
Financing
The study was performed without financial support.
 Algorithm of theoretical substantiation 
of technology of extemporaneous 
infusions та відварів 
Calculation of the amount of active substances according to the prescription 
Finding out possible physicochemical incompatibilities between the 
components of the recipe 
Substantiation of the technology of preparation of infusions and decoctions 
depending on the chemical composition of MPRM, the order of introduction 
of active and auxiliary substances depending on their physicochemical 
properties and taking into account the chemical compatibility  
In-pharmacy quality control 
The choice of packaging depending on the physico-chemical properties of 
the ingredients 
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